July 29th 2025
📰 We are pleased to share an article published in Cath’Lab that highlights the potential of non-invasive ultrasound therapy (NIUT) as an alternative approach for patients with symptomatic severe aortic stenosis (sSAS)
who are not eligible for valve replacement procedures.
The article presents the principles behind this technology developed by Cardiawave, and its ability to soften calcified valve leaflets using focused ultrasound pulses, with the aim of restoring leaflet mobility and improving patient outcomes.
We thank Professor @Emmanuel Messas and the editorial team at Cath’Lab for this detailed and insightful publication.
📖 Read the full article (in French), for subscribers only :
🔗 https://www.cardiologie-pratique.com/cathlab/article/ultrasons-retrecissement-aortique
📖 Read the full article (in French) available on our website :
🔗 https://cardiawave.com/article-cathlab-les-ultrasons-dans-le-retrecissement-aortique/
[Valvosoft® is a medical device exclusively intended for clinical investigations (not CE marked or approved for marketing).]
#Cardiawave #UltrasoundTherapy #AorticStenosis #MedTech #Valvosoft #NonInvasiveTherapy #CardiovascularInnovation #FrenchTech #NIUT
#HEGP, @AP-HP, Assistance Publique – Hôpitaux de Paris @Physics for Medicine Paris, #InstitutLangevin, @CNRS, @ESPCI Paris – PSL, @Inserm @RHU_STOP_AS
#FrenchCare #Health20 @france-biotech @medicen-paris-region @bpi-france @focusedultrasoundfoundation @eic-scalingclub
